Adapalene 0.1%/benzoyl peroxide 2.5% gel reduces the risk of atrophic scar formation in moderate inflammatory acne: a split-face randomized controlled trial.

Author: BissonnetteR, DrenoB, MartelP, RivierM, TanJ

Paper Details 
Original Abstract of the Article :
BACKGROUND: The efficacy of current topical acne treatments in mitigating the potential for acne scarring is not known. OBJECTIVE: To evaluate the effect of adapalene 0.1%/benzoyl peroxide 2.5% (A/BPO) gel compared to vehicle in reducing the risk of acne scarring. METHODS: Multicentre, randomized,...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/jdv.14026

データ提供:米国国立医学図書館(NLM)

Adapalene/Benzoyl Peroxide Gel: A Potential Solution for Acne Scarring

The quest for effective treatments for acne, a common skin condition that can leave lasting scars, continues. This split-face randomized controlled trial investigates the effects of adapalene 0.1%/benzoyl peroxide 2.5% (A/BPO) gel on the risk of atrophic scar formation in moderate inflammatory acne.

A/BPO's Potential to Reduce Scarring

The study found that long-term treatment with A/BPO gel was effective in reducing the risk of atrophic scars and improving the global severity of scarring compared to vehicle control. This finding suggests that A/BPO could be a valuable tool for preventing and minimizing acne scarring.

Managing Acne and Scarring

The research highlights the potential of A/BPO gel to improve not only acne symptoms but also the long-term cosmetic outcomes associated with this condition. It's like finding a natural remedy in the desert, soothing the skin and restoring its health and beauty.

Dr.Camel's Conclusion

This study provides encouraging evidence for the use of adapalene/benzoyl peroxide gel in managing acne and reducing the risk of scarring. Further research is needed to confirm its long-term efficacy, but A/BPO offers a promising option for improving both the treatment and cosmetic outcomes associated with acne.

Date :
  1. Date Completed 2017-11-07
  2. Date Revised 2017-11-07
Further Info :

Pubmed ID

27790756

DOI: Digital Object Identifier

10.1111/jdv.14026

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.